Dr. Boris Lorberg is a psychiatrist board-certified in general psychiatry and child and adolescent psychiatry. He is an Associate Professor of Psychiatry and Pediatrics at UMass Chan-Lahey, within UMass Chan Medical School, and works as a psychiatrist and clinician-educator at the Lawrence Community Behavioral Health Center, part of Beth Israel Lahey Health Behavioral Services, in Massachusetts, USA. His clinical experience spans residential, inpatient, and community care, with a focus on youth with severe and treatment-refractory mental illness.

Born and raised in Kyiv, Ukraine, he earned his medical degree at Stony Brook University, completed his psychiatry residency at Yale University and his child and adolescent psychiatry fellowship at Harvard-affiliated Massachusetts General Hospital/McLean Hospital, and earned a Physician’s MBA at Brandeis University.

Dr. Lorberg co-chairs the American Academy of Child and Adolescent Psychiatry’s (AACAP) Psychopharmacology and Neurotherapeutics Committee and serves as Section Editor for the Psychopharmacology Corner of AACAP News. He has contributed to the AACAP–APA Parent Medication Guides (http://www.parentsmedguide.org) and updates to the IACAPAP Textbook chapter on general psychopharmacology principles (https://iacapaptextbook2.com). He is an author and editor of Pediatric Psychopharmacology Evidence: A Clinician’s Guide (Springer Nature, 2024).

His educational work includes pediatric psychopharmacology, mentorship, and leadership development for clinicians. Since 2018, he has collaborated with Ukrainian child psychiatrists on education and research, including work addressing the mental health of children affected by war.

As coordinator of IACAPAP’s International Pediatric Psychopharmacology SIG, he promotes international collaboration and exchange on medication evidence, guidelines, and clinical practice, with attention to differences in access and resources across countries.